NIH-funded research R21 grant

Creating a 3D heart model to study COVID-19 related heart damage

Official title: Human organoid model for COVID-19 myocarditis

Funded at Clemson University · NIH-10889266 · Data updated 2026-11-12

This study is looking at how COVID-19 can harm the heart, especially a condition called myocarditis, by using tiny 3D models of human hearts made from stem cells, and it's for anyone interested in understanding how immune cells might be involved in heart problems caused by the virus.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionClemson University
NIH-funded
Lab location1 site (Clemson, United States)
Project startJuly 17, 2023
Project endJune 30, 2026
Funding year2024
Award (this year)$179,743
NIH project number5R21HL167211-02
Project IDNIH-10889266 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 who have experienced cardiac injuries related to COVID-19.

Less likely to help

Patients who have not been infected with COVID-19 or do not have any cardiac complications may not benefit from this research.

What this research studies

This research investigates how COVID-19 can cause heart damage, specifically myocarditis, by using advanced 3D human heart organoids. These organoids are created from human stem cells and mimic the structure and function of real human hearts. The study aims to understand the role of immune cells, particularly monocytes, in contributing to heart injuries seen in COVID-19 patients. By examining these interactions in a controlled environment, researchers hope to gain insights that traditional methods have not provided.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and treatment options for heart complications arising from COVID-19.

How similar studies have gone: While there have been studies on COVID-19's impact on the heart, this approach using 3D organoids is relatively novel and has not been extensively tested.

Where this research is happening

  • Clemson University
    Clemson, United States
    Active

Researchers

  • Principal investigator: Mei, Ying — Clemson University
  • Study coordinator: Mei, Ying

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.